First-Ever Blood-Stage Vaccine For Malaria Shows Promising Results In Phase IIb Trial
The RH5.1/Matrix-M blood-stage malaria vaccine shows promise as a crucial secondary defence against malaria, complementing ...
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
Following positive Phase IIb trial results, RH5.1/Matrix-M could be the first blood-stage malaria vaccine brought to market.
Positive interim Phase IIb data shows promise of first blood-stage malaria vaccine
A blood-stage malaria vaccine would not replace pre-erythrocytic vaccines, but provide a second line of defence.